Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

Wondering whether ResMed at around US$220 a share looks like a bargain or a potential value trap? This article walks through what the current price actually reflects about the business. The stock has ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a ...

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...

The Swiss institution bolstered its position by acquiring over 32,000 additional shares last quarter. UBS now manages a stake valued at approximately $218 million. This endorsement from a major ...

I've been sleeping on ResMed (NYSE: RMD) stock, not paying much attention to it at all. But maybe I shouldn't ignore it -- ...

Resmed Inc. RMD keeps expanding its mask portfolio through product innovation and targeted initiatives to drive mask resupply ...

A leading expert delivers his verdict on the outlook for ResMed shares. The post With global populations ageing, are ResMed ...

ResMed is on a mission to cement the lead it’s built while competitor Philips has been out of the CPAP machine-making game. That process of building out its market share for the long-term has recently ...

Shares of ResMed Inc. RMD rallied 1.25% to $233.50 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.25% to 6,716.09 and ...